This is a longitudinal, multi-center, observational study collecting diverse biological measurements and clinical and epidemiological data for the purpose of enabling a greater understanding of the onset of severe outcomes, primarily acute respiratory distress syndrome (ARDS) and/or mortality, in patients presenting to the hospital with suspicion or diagnosis of COVID-19. We seek to understand whether there are early signatures that predict progression to ARDS, mortality, and/or other comorbid conditions. The duration of the study participation is approximately 3 months.
Inclusion Criteria:
- Participant or legally authorized representative willing and able to provide informed
consent
- Receiving care at a participating site
- Age 18 years old or older
- U.S. Resident
- Confirmed positive for COVID-19
- Willing and able to comply with all study procedures
Exclusion Criteria:
- Self reported pregnancy
The University of Arizona
Tucson, Arizona, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
University of Illinois at Chicago
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Weill Cornell Medical College
New York, New York, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
Inova Health Care Services
Falls Church, Virginia, United States